Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update

for the NEURO-T. T. R. Open-Label Extension Investigators

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update'. Together they form a unique fingerprint.

Medicine & Life Sciences